Suchergebnisse - "Gunale, Bhagwat"

PubPharm (30)

1

Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine) : 6-month follow-up of a randomized, controlled, observer-blind, phase 2/3 immuno-bridging study in Indian adults

enthalten in: Human vaccines & immunotherapeutics | 2024

von Kulkarni, P. | Padmapriyadarsini, C. | Vekemans, J. | +29

2

An observer-blind, randomised, placebo-controlled, phase 1, single ascending dose study of dengue monoclonal antibody in healthy adults in Australia

enthalten in: The Lancet. Infectious diseases | 2024

von Gunale, B. | Farinola, N. | Kamat, C. | +5

3

Post-marketing safety surveillance of the rotavirus vaccine in India

enthalten in: Vaccine: X | 2023

von Kang, G. | Lakhkar, A. | Bhamare, C. | +7

4

A Phase 2/3 observer-blind, randomized, controlled study to determine the safety and immunogenicity of SARS-CoV-2 recombinant spike protein vaccine in Indian children and adolescents aged 2 to 17 years

enthalten in: bioRxiv.org | 2023

von Gunale, B. | Kapse, D. | Kar, S. | +23

5

A Phase 3, randomized, non-inferiority study of a heterologous booster dose of SARS CoV-2 recombinant spike protein vaccine in adults

enthalten in: Scientific reports | 2023

von Kulkarni, P. | Gunale, B. | Kohli, S. | +41

6

A Phase 1, double-blind, randomized, placebo-controlled study to evaluate the safety and immunogenicity of a tetravalent live attenuated dengue vaccine in adults

enthalten in: Vaccine | 2023

von Gunale, B. | Farinola, N. | Yeolekar, L. | +8

7

Safety and Immunogenicity of SARS-CoV-2 Recombinant Spike Protein Vaccine in Children and Adolescents in India : A Phase 2-3 Randomized Clinical Trial

enthalten in: JAMA pediatrics | 2023

von Gunale, B. | Kapse, D. | Kar, S. | +50

8

Active safety surveillance of rabies monoclonal antibody and rabies vaccine in patients with category III potential rabies exposure

enthalten in: The Lancet regional health. Southeast Asia | 2023

von Kang, G. | Lakhkar, A. | Bhamare, C. | +7

9

Safety and immunogenicity of SII-NVX-CoV2373 (COVID-19 vaccine) in adults in a phase 2/3, observer-blind, randomised, controlled study

enthalten in: The Lancet regional health. Southeast Asia | 2023

von Kulkarni, P. | Kadam, A. | Godbole, S. | +81

10

A phase 2/3, participant-blind, observer-blind, randomised, controlled study to assess the safety and immunogenicity of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine) in adults in India

enthalten in: EClinicalMedicine | 2021

von Kulkarni, P. | Padmapriyadarsini, C. | Vekemans, J. | +29